NX1.AX · NEXALIS THERAPEUTICS LTD
Australia · RS rating 10 · As of 2026-10-14
| Price | 0.01 AUD |
|---|---|
| 1-day change | +0.0% |
| RS rating (overall / 1M / 3M / 12M) | 10 / 32 / 24 / 8 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 16 / 2 / 1 |
| Industry group (rank) | Medical-Biomed/Biotech (–) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +75.0% |
| Market cap (USD) | $2.6M |